Manhattan Scientifics, Inc. announced that its Senior Scientific unit, developing a platform for the early detection of cancer and other human diseases, has established a Research Collaboration with The University of Michigan Medical School. The collaboration's goal is to demonstrate the applicability of the company's magnetic relaxometry technology for diagnosing and staging breast cancers.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.001 USD | -9.09% | -9.09% | -61.54% |
1st Jan change | Capi. | |
---|---|---|
-61.54% | 559K | |
0.00% | 404M | |
+0.73% | 332M | |
-11.45% | 147M | |
-.--% | 139M | |
+11.38% | 86.04M | |
+100.00% | 67.71M | |
+19.50% | 49.82M |
- Stock Market
- Equities
- MHTX Stock
- News Manhattan Scientifics, Inc.
- Manhattan Scientifics, Inc. Teams Up with University of Michigan Medical School on In Vivo Breast Cancer Diagnostic